Monoclonal and Polyclonal Antibodies
Since many years, CliniSciences has been offering a comprehensive range of custom solutions for the development of monoclonal and polyclonal antibodies tailored to research, diagnostic, and therapeutic applications.
Our dedicated scientific team collaborates closely with clients to understand the unique challenges of each project and design customized strategies. Each project is structured into multiple phases, allowing clients to actively participate and evaluate intermediate materials at key stages.
1. Project Specifications
Listening to our clients is at the core of our services. For each project, our team collaborates closely with the client to thoroughly understand the challenges and define the specifications.
- Target of Interest: Membrane protein, peptide, small molecule, post-translational modifications, etc.
- Applications: ELISA, WB, FACS, IF, IHC, IP, functional assays, diagnostic or therapeutic applications, etc.
- Specific Considerations: Available materials, specificity, timelines, etc.
Taking these various factors into account, CliniSciences develops tailor-made strategies to address client challenges and ensure project success.
2. Customized Strategies
Leveraging its expertise and know-how, our team delivers high-quality services for the generation of monoclonal and polyclonal antibodies.
With access to a comprehensive suite of technologies, we successfully manage ambitious projects and offer clients exclusive, high-value-added solutions.
From the production and preparation of immunogens/antigens to immunizations, screening, and antibody production, we provide complete and tailored solutions to meet the needs of the scientific community.
3. Tailored Development
Each project is organized into distinct phases, allowing clients to evaluate the generated biologics at key milestones and decide whether to proceed with the project (Go/No Go).
We ensure personalized support, including regular updates and detailed reviews of project outcomes, to keep clients informed and in control throughout the process.
4. Client Testing
Throughout the project, clients have the opportunity to test the generated biologics (e.g., sera, supernatants, oligoclonal antibodies, monoclonal antibodies) to identify and validate candidates of interest for their specific systems and applications.
Additional services can also be provided to further characterize the best antibody candidates, facilitating intellectual property protection such as patent filing.
5. Production & Client Satisfaction
Antibodies of interest can be produced at large scales according to client requirements, with production capacities ranging from milligrams to several grams.
All our services operate on a 100% fee-for-service model, with CliniSciences retaining no rights to the developed antibodies.
